tetradecanoylphorbol acetate has been researched along with 16-fluoro-5-androsten-17-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lewbart, ML; Pashko, LL; Schwartz, AG | 1 |
| Pashko, LL; Schwartz, AG | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and 16-fluoro-5-androsten-17-one
| Article | Year |
|---|---|
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16 alpha-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides.
Topics: Androstenes; Animals; Body Weight; Deoxyribonucleosides; Drug Interactions; Female; Mice; Mice, Inbred Strains; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1991 |
Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and inflammation by the dehydroepiandrosterone analog 16alpha-fluoro-5-androsten-17-one and its reversal by NADPH liposomes.
Topics: Androstenes; Animals; Antineoplastic Agents; Binding, Competitive; Capillary Permeability; Carcinogens; Cations; Corticosterone; Dehydroepiandrosterone; DNA; Epidermis; Female; Free Radicals; Hyperplasia; Inflammation; Liposomes; Mice; NADP; Tetradecanoylphorbol Acetate | 2001 |